Verona Pharma

VRNA

0 Obserwujący

$66.28

+0.02%

$0.02

Obserwuj

14 Sierpień

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

VRNA Fair Price

$13.16

Overvalued by 19.1%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

My Notes

Začít psát

Profile

Verona Pharma is a UK-based biotechnology company specializing in the development of drugs targeting respiratory diseases, particularly chronic lung diseases such as chronic obstructive pulmonary disease (COPD) and asthma. The company is focused on developing innovative therapeutic options aimed at improving lung function and reducing inflammation in the airways. Verona Pharma concentrates on researching and developing medicines that can improve the quality of life for patients suffering from these chronic respiratory conditions.

Feed

There are no posts to show right now.